Predictive value of minimal residual disease on efficacy of rituximab maintenance in mantle cell lymphoma: Results from the European MCL Elderly trial Meeting Abstract
| Authors: | Hoster, E.; Delfau, M. H.; Macintyre, E. A.; Jiang, L. M.; Stilgenbauer, S.; Vehling-Kaiser, U.; Salles, G.; Thieblemont, C.; Tilly, H.; Kanz, L.; Feugier, P.; Huebel, K.; Schmidt, C.; Ribrag, V.; Kluin-Nelemans, H.; Dreyling, M.; Pott, C. |
| Abstract Title: | Predictive value of minimal residual disease on efficacy of rituximab maintenance in mantle cell lymphoma: Results from the European MCL Elderly trial |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 1304 |
| End Page: | 1306 |
| Language: | English |
| ACCESSION: | WOS:000893223201130 |
| DOI: | 10.1182/blood-2022-159932 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
